GH1 and pulmonary arterial hypertension: The height gain (FAH–initial PAH) was 9.22 ± 6.03 cm in patients treated with GnRHa + GH, which was significantly higher than the 4.72 ± 5.01 cm in those treated with GnRHa alone (P < 0.001).